Susana Vives - Concepedia

Author

Susana Vives

Also Known As

Jordi Esteve, Jordi Ribera, Juana Pérez Galmés Palmer, Mireia Morgades, Montserrat Batlle, Neus Solanes, Pere Barba, S Vives, S. Vives, Susana Vives

190

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Hospital Universitari i Politècnic La Fe Josep Carreras Leukaemia Research Institute Hospital Clínico Universitario de Valencia Hospital San Pedro de Alcántara

About

Susana Vives is an author at Universitat Autònoma de Barcelona specializing in medicine, hematology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	361
2	Health Sciences	7	7	269
3	Biomedical Engineering	1	1	13
4	Biostatistics	1	1	12
5	Blood Transplantation	1	1	13

Susana Vives

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Ivosidenib and Azacitidine in <i>IDH1</i> -Mutated Acute Myeloid Leukemia Pau Montesinos, Christian Récher, Susana Vives, New England Journal of Medicine	2022	448
Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group Albert Oriol, Susana Vives, Jesús María Hernández‐Rivas, Haematologica	2010	289
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes Rafael Díaz de la Guardia, Belén López‐Millán, Jessie R. Lavoie, Stem Cell Reports Cell TherapyDevelopmental BiologyDetailed CharacterizationMedicineHematology	2017	97
41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo Matteo Libero Baroni, Diego Sánchez‐Martínez, Francisco Gutiérrez Agüera, Journal for ImmunoTherapy of Cancer	2020	63
Treatment patterns and outcomes of 2310 patients with secondary acute myeloid leukemia: a PETHEMA registry study David Martínez‐Cuadrón, Juan Eduardo Megías‐Vericat, Josefina Serrano, Blood Advances Surgical OncologyMixed-phenotype Acute LeukemiaPathologyTumor BiologyInternal Tandem Duplication	2021	61
Predictive factors for poor peripheral blood stem cell mobilization and peak CD34+cell count to guide pre-emptive or immediate rescue mobilization. Juan‐Manuel Sancho, Mireia Morgades, Joan-Ramon Grífols, Cytotherapy Cell TherapyPeak Cd34+cell CountImmediate Rescue MobilizationMedicinePredictive Factors	2012	55
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol Álex Bataller, Ana Garrido, Francesca Guijarro, Blood Advances	2021	54
Acute myeloid leukemia with <i>NPM1</i> mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease Álex Bataller, Guadalupe Oñate, Marina Díaz‐Beyá, British Journal of Haematology	2020	41
Prognostic impact of <i>DNMT3A</i> mutation in acute myeloid leukemia with mutated <i>NPM1</i> Guadalupe Oñate, Álex Bataller, Ana Garrido, Blood Advances	2021	34
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Tomás Palanques-Pastor, Juan Eduardo Megías‐Vericat, Pilar Martı́nez, Leukemia & lymphoma/Leukemia and lymphoma	2021	33

Page 1